A systematic review of validated methods for identifying pancreatitis using administrative data

被引:32
作者
Moores, Kevin [1 ,2 ]
Gilchrist, Bradley [1 ,2 ]
Carnahan, Ryan [3 ]
Abrams, Thad [4 ,5 ]
机构
[1] Univ Iowa, Coll Pharm, Div Drug Informat Serv, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Pharm, Iowa Drug Informat Serv, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA
[4] Univ Iowa, Dept Internal Med, Div Gen Internal Med, Carver Coll Med, Iowa City, IA 52242 USA
[5] Iowa City Vet Affairs Med Ctr, Ctr Implementat Innovat Strategies Practice, Iowa City, IA USA
关键词
pancreatitis; validity; administrative data; OUTCOMES; TRENDS; RISK;
D O I
10.1002/pds.2334
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Purpose To systematically review algorithms identifying cases of pancreatitis in administrative data, with a focus on studies examining algorithm validity. Methods A literature search was conducted using PubMed and the Iowa Drug Information Service database. Reviews were conducted by two investigators identifying studies using data sources from the USA or Canada. These data sources most likely reflect the coding practices of Mini-Sentinel data partners. Results Eight studies were obtained examining the validity of an algorithm to identify pancreatitis in either hospital or ambulatory medical records or billing databases. The best-performing algorithm was International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) code 577.0; with a positive predictive value of 60%-80% and a negative predictive value usually greater than 90%. Populations involved in different studies were heterogeneous; age ranges, level of population risk, pancreatitis etiology, and geographic distribution were highly variable. Conclusions Validation studies find that the principal ICD-9-CM diagnosis code of 577.0 had the best positive predictive value and specificity. Current studies do not support the use of the ICD-9-CM codes 577.1 and 577.2. Databases enhanced with laboratory values at point of care would invariably increase the specificity of existing algorithms. Copyright (C) 2012 John Wiley & Sons, Ltd.
引用
收藏
页码:194 / 202
页数:9
相关论文
共 15 条
  • [1] [Anonymous], PANCREAS
  • [2] Drug-induced acute pancreatitis: An evidence-based review
    Badalov, Nison
    Baradarian, Robin
    Iswara, Kadirawel
    Li, Jianjun
    Steinberg, William
    Tenner, Scott
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2007, 5 (06) : 648 - 661
  • [3] Practice guidelines in acute pancreatitis
    Banks, Peter A.
    Freeman, Martin L.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (10) : 2379 - 2400
  • [4] Brown A, 2008, J PANCREAS, V9, P408
  • [5] Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned
    Carnahan, Ryan M.
    Moores, Kevin G.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 82 - 89
  • [6] Stratum-specific positive predictive values of claims for acute pancreatitis among commercial health insurance plan enrollees with diabetes mellitus
    Dore, David D.
    Chaudhry, Saadia
    Hoffman, Clorinda
    Seeger, John D.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (02) : 209 - 213
  • [7] Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
    Dore, David D.
    Seeger, John D.
    Chan, K. Arnold
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (04) : 1019 - 1027
  • [8] AGA institute technical review on acute pancreatitis
    Forsmark, Chris E.
    Baillie, John
    [J]. GASTROENTEROLOGY, 2007, 132 (05) : 2022 - 2044
  • [9] Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus
    Guo, JJ
    Jang, R
    Louder, A
    Cluxton, RJ
    [J]. PHARMACOTHERAPY, 2005, 25 (08): : 1044 - 1054
  • [10] McMenamin DA, 1996, AM J GASTROENTEROL, V91, P1384